"cCARE (California Cancer Associates for Research & Excellence) serves the greater San Diego and Fresno communities. Our mission is to provide quality and value in cancer treatment, hematology and other patient health services through a network of doctors and providers who are focused on outcomes, research and personalized care."

During the past decade, California Cancer Associates for Research & Excellence, Inc. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Cancer Associates for Research & Excellence, Inc." #1 sponsor was "HUYABIO International, LLC." with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Regeneron Pharmaceuticals" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Cancer Associates for Research & Excellence, Inc." #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "California Cancer Associates for Research & Excellence, Inc." are "Colorectal Cancer" (3 trials), "Melanoma" (3 trials), "Advanced Melanoma" (2 trials), "Breast Cancer" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "California Cancer Associates for Research & Excellence, Inc." in a lesser frequency.

Most popular intervention types in "California Cancer Associates for Research & Excellence, Inc." are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "CMP-001" (2 trials), "Cisplatin" (2 trials), "Docetaxel" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "California Cancer Associates for Research & Excellence, Inc." are 11 trials for "All" genders.

Currently, there are NaN active trials in "California Cancer Associates for Research & Excellence, Inc.". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in California Cancer Associates for Research & Excellence, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in California Cancer Associates for Research & Excellence, Inc., 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".